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Bacteriophage infection has profound effects on bacterial biology. Clustered regular interspaced short
palindromic repeats (CRISPRs) and cas (CRISPR-associated) genes are found in most archaea and many
bacteria and have been reported to play a role in resistance to bacteriophage infection. We observed that
lysogenic infection of Pseudomonas aeruginosa PA14 with bacteriophage DMS3 inhibits biofilm formation and
swarming motility, both important bacterial group behaviors. This inhibition requires the CRISPR region in
the host. Mutation or deletion of five of the six cas genes and one of the two CRISPRs in this region restored
biofilm formation and swarming to DMS3 lysogenized strains. Our observations suggest a role for CRISPR
regions in modifying the effects of lysogeny on P. aeruginosa.
behaviors of this bacterium. Furthermore, we show that the
loss of biofilm formation and swarming motility requires clustered
regular interspaced short palindromic repeats (CRISPRs) and
five of six cas (CRISPR-associated) genes. Our data suggest a
complex interaction between microbe and bacteriophage impacts
the group behaviors of P. aeruginosa.

Bacteriophages are probably best known for their role as
tools used to study bacteria. Phages have also served as important models for the study of mechanisms of transcription, recombination, and transposition (8). Bacteriophages also shape
microbial populations both by impacting the size and structure
of bacterial communities and through the transfer of genetic
material between bacterial strains (6, 39, 52). It is estimated
that phages can lyse as many as 20% of all bacterial cells daily;
therefore, these infectious particles can have a profound impact on the evolution of microbes (53).
While some bacteriophage infections are primarily lytic,
temperate or lysogenic bacteriophages often integrate into the
bacterial genome as a prophage causing a chronic infection of
the host bacterium (52). In some cases, genes carried by a
bacteriophage confer a new function upon a bacterium, typically not directly related to the phage life cycle, through a
process known as lysogenic conversion. Lysogenic conversion
likely supports phage survival indirectly by increasing the fitness of the host microbe, thus promoting the continued persistence of the phage genome within the host population. Examples of this phenomenon include the phage-mediated
introduction of secreted virulence factors such as cholera toxin
(30), altered lipopolysaccharide profile (35), and improved adhesion to epithelial cells (50).
Here we report that infection of Pseudomonas aeruginosa
PA14 by phage DMS3 results in lysogenized strains unable to
form a biofilm or undergo swarming motility—two key group

MATERIALS AND METHODS
Bacterial and phage culture preparation. Strains and plasmids used in this
study are shown in Table 1. Overnight cultures were streaked from glycerol
stocks stored at ⫺80°C onto lysogeny broth (LB) agar (1.5%) and incubated
overnight at 37°C to isolated single colonies. These colonies were then used to
inoculate planktonic and biofilm assays. Phage stocks were generated by growing
lysogenized strains overnight in liquid LB at 37°C. The phage was purified from
the lysogenized strains by passage of the culture through a 0.22-m filter.
Generation of phage lysogens and measurements of phage titer. To generate
phage lysogens, 10 l of filtered lysate containing phage (prepared as described
above) was mixed with 10 l Pseudomonas aeruginosa PA14 cells from an overnight LB-grown culture, and the mixture of PA14 and phage was incubated
overnight at 37°C in LB medium. These bacterium-phage mixtures were then
struck on plates to obtain individual colonies. Individual colonies were inoculated into liquid LB medium, grown overnight, and then assayed for the presence
of phage. Phage production was quantified by spotting 10-l serial dilutions of
the phage lysate on a lawn of wild-type (WT) PA14 grown in LB top agar, and
the plates were incubated at 37°C overnight as reported previously (7). Plaques
were counted to yield the phage titer expressed as PFU/ml.
Biofilm assays. (i) Ninety-six well dish assay. Biofilm formation in microtiter
dishes was measured as described previously (37). Briefly, microtiter wells were
inoculated from overnight LB-grown cultures diluted 1:100. Cells were grown for
24 h at 37°C before they were stained with crystal violet and quantified by
dissolution using 30% acetic acid and measured at an absorbance at 550 nm (37).
(ii) CFU of biofilms in microtiter wells. CFU associated with biofilms attached
to the sides of microtiter wells were determined as previously described (18).
(iii) Air-liquid interface assay. The attachment on plastic was measured using
an air-liquid interface assay as reported previously (31).
Planktonic growth assays. All strains were streaked to single colonies on LB
agar plates. A single colony of each strain was picked, inoculated into 3 ml of LB
broth, and incubated on a rotating shaker at 37°C overnight. One hundred
microliters of each culture was then inoculated into 100 ml of fresh LB broth and
incubated at 37°C. At appropriate time points, samples of the culture were
obtained and serial dilutions made on LB agar to determine the CFU.
Swarming assays. Swarming assays were performed as reported previously (19, 49).
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TABLE 1. Strains and plasmids used in this study
Strain

Strains
S. cerevisiae strain
INVSc1
E. coli strain
Top10
P. aeruginosa strains
PA14
SMC3899
SMC3884
SMC3897
SMC3898
SMC3896
SMC3885
SMC3892
SMC3886
SMC3887
SMC3888
SMC3889
SMC3890
SMC3891
SMC3893
SMC3895
SMC3894
Plasmids
pCR2.1-TOPO
pMQ30
pMQ70
pMQ78
pCR2.1-TOPO-DMS3Early
pDMS3Early
pMQ30-⌬CRISPR-1
pMQ30-⌬CRISPR-2
pMQ30-⌬PA14_33300
pMQ30-⌬PA14_33310
pMQ70-PA14_33310

Relevant phenotype or description

Source or reference

MATa his3D1 leu2 trp1-289 ura3-52 MAT his3D1 leu2 trp1-289 ura3-52

Invitrogen

F⫺ mcrA ⌬(mrr-hsdRMS-mcrBC) 80lacZ⌬M15 ⌬lacX74 recA1 ara⌬139
⌬(ara-leu)7697 galU galK rpsL (Strr) endA1 nupG

Invitrogen

WT
LysNeg2, biofilm-negative DMS3 lysogen
LysNeg6, biofilm-negative DMS3 lysogen
LysNeg8, biofilm-negative DMS3 lysogen
LysNeg10, biofilm-negative DMS3 lysogen
LysPos5, biofilm-positive DMS3 lysogen
LysPos6-3, biofilm-positive DMS3 lysogen
LysNeg6 33310::TnM
PA14_33290::TnM
PA14_33310::TnM
PA14_33320::TnM
PA14_33330::TnM
PA14_33340::TnM
PA14_33350::TnM
⌬CRISPR-1
⌬CRISPR-2
⌬PA14_33300

41
This
This
This
This
This
This
This
23
23
23
23
23
23
This
This
This

Cloning vector
Cloning vector
Cloning vector
c-repressor construct
c-repressor expression construct
CRISPR-1 deletion construct
CRISPR-2 deletion construct
PA14_33300 deletion construct
PA14_33310 deletion construct
PA14_33310 complementation construct

Invitrogen
44
44
44
This study
This study
This study
This study
This study
This study
This study

Initial phage sequencing. Phage DNA was isolated from a lysate of DMS3 as
reported previously (7). Agencourt Biosciences Corporation performed the construction of the clone library of the phage and sequencing of the clones. Threeor 4-kb-insert-length libraries were constructed in the vector pAGEN-HC by use
of the BstXi restriction enzyme. The DNA was cleaved using a Hydroshear
device (Genemachines, San Carlos, CA) and ligated to an adapter to facilitate
ligation into the BstI site of the vector. DNA templates were then sequenced in
a 384-well format with forward and reverse reactions utilizing BigDye version 3.1.
The Paracel genome assembler (TIGR) coupled with Agencourt’s laboratory
information management system was used to assemble the DNA sequence. The
average coverage of the genome was approximately 21.5⫻.
Supplementary phage sequencing. Preliminary analysis of the phage DMS3
sequence suggested that a portion of the left end of the DMS3 genome was
missing from the assembled contig derived from the phage genomic sequence
based on the lack of start codon for an otherwise highly conserved gene at the
leftmost end of the phage sequence (DMS3-4 in the final annotation). Due to the
high degree of similarity between phages D3112 (51) and DMS3 at the left ends
of the respective genomes, it was hypothesized that primers could be designed
based on the D3112 sequence to amplify their corresponding regions in DMS3
(see Table S1 in the supplemental material). PCR primers to the left end of the
known genomic sequence of DMS3 from Agencourt and to the third annotated
gene of D3112 yielded an ⬃1.4-kb PCR product when DMS3 DNA was used as
the template. Determination of the nucleotide sequences of PCR products was
performed by first cloning the products into vector pBAD-TOPO, followed by
DNA sequencing. The process was repeated with an additional primer set designed to the first and the third annotated genes of D3112.
Finally, arbitrary primed PCR was used to determine the ⬃300 bp at the
leftmost end of DMS3. Arbitrary primed PCR was performed as reported previously (37) using primers to the known phage genome sequence in conjunction

study
study
study
study
study
study
study

study
study
study

with two arbitrary PCR primers, designated P15 and P16 (see Table S1 in the
supplemental material), that were added in equal amounts to the first-round
reaction mix. DNA purified from lysogens was used as the template for the first
round of PCR. Products of the first-round reaction were used as template in the
second round, with the original phage primer and a primer, designated P14, that
hybridizes to the 5⬘ end of primers P15 and P16.
Sequence assembly. The sequences generated by the PCR, arbitrary PCR, and
direct sequencing were assembled with the help of the Lasergene software suite
(DNAstar, Inc.). Multiple alignments were generated with GeneInspector version 1.6 (Textco, West Lebanon, NH). The nucleotide sequence of the left end
of DMS3 was confirmed by sequencing multiple PCR products (99.88% of bases
confirmed by at least two separate PCRs) to eliminate errors during amplification steps.
Genome annotation. The initial annotation of the DMS3 sequence was performed by searching for similarities between putative translated protein sequences and proteins in the NCBI database by BLASTX (1). The entire genome
was also analyzed by GeneMark.hmm for prokaryotes version 2.4 (25; http://opal
.biology.gatech.edu/GeneMark/gmhmm2_prok.cgi) with P. aeruginosa as the selected species. The potential open reading frames (ORFs) identified were
marked and translated using gene construction kit 2.5 (Textco, West Lebanon,
NH). Each putative protein identified was compared to the NCBI database using
BLASTP with alignments created using the default settings. Discrepancies between BLASTX and GeneMark.hmm analysis at the beginnings and/or ends of
translated regions were resolved by first examining predicted start and stop
codons to determine if they matched known start and stop codons, followed by
assessing the presence and strength of ribosomal binding sites and determining
the lowest expect value compared to those for proteins in the NCBI database.
Transcriptional units were predicted with the help of FGENESB (SoftBerry, Mt.
Kisco, NY) set to the generic bacterial genome setting and utilizing default
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settings. Promoters were predicted using the Berkeley Drosophila Genome
Project neural network promoter program (http://www.fruitfly.org/seq_tools
/promoter.html) set for prokaryotes and including the forward and reverse
strands and with BPROM bacterial promoter predictor (SoftBerry, Mt. Kisco, NY;
http://www.softberry.com/berry.phtml?topic⫽bprom&group⫽programs&subgroup
⫽gfindb). Neither program was specific for P. aeruginosa. The entire genome was
also subjected to BLASTN analysis to search for any regions of similarity at the
nucleotide level (1).
Detection of ribosomal binding sites. Ribosomal binding sites in the area
upstream of possible start codons were identified by an algorithm utilizing dynamic programming to align the consensus P. aeruginosa Shine-Dalgarno sequence (TAAGGAGGTGAT) (26) within the area 20 bp upstream of the suspected ORF. The scoring for the dynamic programming was based on the rules
developed for changes in RNA duplex free energy by Freier et al. (10). This
algorithm, which we named RBSLocator, was written in the Java language and
was described and utilized previously (26, 43).
ORF analysis. Searches for helix-turn-helix motifs were carried out with GYM
2.0 (http://www.cs.fiu.edu/⬃giri/bioinf/GYM2/prog.html) (11, 34). Phylogram
trees to assess the relatedness of proteins were created for all hypothetical
proteins which contained similarity to more than three proteins in the NCBI
database as determined by BLASTP expect values under 1e–19. Phylograms
were created using ClustalX (version 1.8) (available at http://www.uk.plbio.kvl
.dk/bioinfo.htm) utilizing default parameters (48). Neighbor-joining trees were
also created with the ClustalX program and bootstrapped with random-number
seeds of 111 and 1000 bootstrap replicates. Trees were visualized with Treeview
(38). Conserved protein domains were detected as part of the BLASTP, as
reported previously (28). A search for potential tRNA genes was carried out with
tRNAscan-SE utilizing default settings (http://lowelab.ucsc.edu/tRNAscan-SE/)
(24).
GⴙC analysis of genome. G⫹C analysis of the DMS3 genome along with
calculations of ORF G⫹C percent content was performed with Artemis release
7 (http://www.sanger.ac.uk/Software/Artemis/) (42).
Identification of DMS3 insertion in the P. aeruginosa genome. The PCR
products of the arbitrary primed PCRs, using the arbitrary primers and a primer
derived from sequence of the leftmost end of the phage genome (P01 reverse 3),
were sequenced and aligned to the PA14 genome by use of the BLASTN
program from NCBI to indicate a potential site for insertion in the P. aeruginosa
chromosome. Once a putative site of DMS3 insertion was established, genomic
DNA was purified from the lysogenic strain by use of the Puregene genomic
DNA purification kit (Gentra, Minneapolis, MN). Primers were then designed
specific to the PA14 region identified and were used to establish whether formation of the PCR product was blocked in the lysogen, indicating the insertion
of the phage at that site. Additionally, the appropriate primer was paired with an
upstream or downstream primer to DMS3 in order to generate a PCR product
containing sequence including the junction point of DMS3 and the flanking P.
aeruginosa genome sequence. These products were also sequenced to confirm the
presence of DMS3 in a particular insertion site in the PA14 genome and to
determine the precise junction point of the phage and bacterial genomes.
Cloning of the DMS3 immunity region. The region of phage DMS3 containing
the predicted DMS3 c-repressor gene was cloned into vector pMQ78, which
contains a gfp gene, in order to create a transcriptional fusion (44). The crepressor ORF and flanking sequence were amplified with primers CRepFor
(containing an engineered Acc651 restriction site) and DMS3p03 Reverse and
then cloned into vector pCR2.1-TOPO (Invitrogen), yielding plasmid pCR2.1DMS3Early. Plasmid pCR2.1-DMS3Early was restricted with enzymes Acc651
(New England Biolabs) and EcoRI (Invitrogen), yielding an ⬃2 kb fragment
which was gel purified and then ligated into pMQ78 to yield plasmid
pDMS3Early. Plasmid pDMS3Early was propagated in Escherichia coli JM109
cells and then electroporated into competent P. aeruginosa cells as reported
previously (3). The presence of the vector and the transcription of the c-repressor
ORF were confirmed by visualization of green fluorescent protein expressed
downstream of the c-repressor ORF from the pMQ78 plasmid by epifluorescence microscopy (not shown).
Mariner transposon mutagenesis of LysNeg6. The biofilm-negative DMS3lysogenized LysNeg6 in the PA14 background was mutagenized using the mariner transposon (designated TnM) as previously described (22). Briefly, the
mariner transposon was conjugated into the LysNeg6 strain. Exconjugants were
plated in the presence of 50 g/ml gentamicin. Individual colonies were picked
and grown overnight in 96-well plates under selective conditions. The mutants
were then screened for biofilm formation in the microtiter dish assay described
above using M63 medium supplemented with 1 mM MgSO4 and 0.4% arginine.
Swarming was tested for candidate mutants as described above.
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Identification of CRISPR and cas genes. Identification of the CRISPRs and
spacers in PA14 was aided by the use of CRISPERFinder (13) and CRISPRdb
(12). Each spacer was also compared against the NCBI database manually.
qRT-PCR. Quantitative real-time PCR (qRT-PCR) of the cas genes in the WT
and in the biofilm-positive and biofilm-negative lysogenized strains was performed as reported previously (20, 21) with the following modifications. The
strains of interest were subcultured from a single plate colony into 5 ml LB at
37°C until they reached an optical density at 600 nm of ⬃0.4. Cells were normalized to an optical density at 600 nm of 0.4. One milliliter of culture was
removed and centrifuged to pellet the cells, RNA was isolated, and cDNA was
prepared as previously reported (20, 21). qRT-PCR was performed and the
expression levels were quantified and normalized to rplU by use of previously
published primers (20, 21). Expression levels are reported in picograms of input
cDNA. The primers used in the qRT-PCR assays to measure the expression of
the indicated genes were as follows: for PA14_33300, 33300amp.forward and
33300amp.Reverse; for PA14_33310, 33310amp.forward and 33310amp.Reverse;
and for PA14_33320, 33320amp.forward and 33320amp.Reverse.
Expression of selected cas genes was also assessed by qRT-PCR in the WT
grown planktonically and attached to a surface for 30 min. Fifty-milliliter cultures
of the WT were grown in minimal arginine medium until late log phase (⬃16 h)
and 500-l cultures transferred to wells of a 24-well polystyrene plate. After a
30-min incubation standing at 37°C, the planktonic cells from six wells were
removed and pooled and RNA was prepared using the Qiagen RNAEasy kit, as
described by the manufacturer with the recommended concentration of lysozyme. Lysis buffer (350 l) plus lysozyme was added to the same six wells, the
buffer from pairs of cells pooled, and RNA isolated with a Qiagen RNAEasy kit
as described by the manufacturer. The RNA of the biofilm cells from all six wells
was pooled and represented a single sample. The protocol above was performed
three times independently, and the triplicate RNA samples (both from planktonic and biofilm cells) was subjected to qRT-PCR of the indicated genes.
Construction of CRISPR region mutants and complementing plasmids.
Transposon mutations in genes PA14_33290, PA14_33310, PA14_33320,
PA14_33330, PA14_33340, and PA14_33350 were obtained from the PA14nr
library (23).
Clean deletions of CRISPR-1, CRISPR-2, PA14_33300, and PA14_33310
were also constructed (Table 1). The pMQ30-⌬CRISPR-1, pMQ30-⌬CRISPR-2,
pMQS30-⌬33300, and pMQ30-⌬33310 constructs were created utilizing the Saccharomyces cerevisiae recombineering technique described by Shanks et al. (44).
Constructs were electroporated into Escherichia coli and analyzed by colony
PCR or sequencing. Plasmids pMQ30-⌬CRISPR-1, pMQ30-⌬CRISPR-2, and
pMQ30-⌬33300 were propagated in E. coli S17 and conjugated into P. aeruginosa
strain PA14, while plasmid pMQ30-⌬33310 was electroporated (3). Exconjugants
containing an inserted plasmid were selected on gentamicin. Mutants were isolated as reported previously (20, 21). All mutations were confirmed via PCR
amplification and sequencing of the mutated region.
The PA14_33310 complementation construct was cloned utilizing primers
PA14_33310 F and PA14_33310 R. The PCR product and vector pMQ70 were
restricted with EcoR1 and HindIII at 37°C, gel purified, and then ligated and
transformed into competent DH5␣ cells via electroporation. Colonies were selected based on the ability to grow under ampicillin selection. The PA14_33310
complementation construct or the vector control was purified from DH5␣ cells
by use of a Qiagen miniprep kit and electroporated into the ⌬PA14_33310
mutant strain. Transformants were selected on LB agar containing 250 g/ml
carbenicillin.
Nucleotide sequence accession number. The complete sequence of DMS3 was
deposited in GenBank (accession number DQ631426).

RESULTS
Lysogeny by phage DMS3 blocks biofilm formation and
swarming by P. aeruginosa PA14. While working with microbes
lysogenized with bacteriophage DMS3 (7) in a P. aeruginosa
PA14 background, we observed a loss in the ability of the
lysogenized microbe to form biofilms (Fig. 1A, B, C, and D;
compare WT with LysNeg6 column). Microscopy studies indicated that the defect in biofilm formation occurred at an early
stage in the formation of these communities. At 8 h, there were
⬃10-fold fewer bacteria attached for the LysNeg6 strain than
for the WT (Fig. 1D). This difference in attachment could be
observed as soon as 30 min postinoculation with 50% fewer
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FIG. 1. Biofilm and swarming phenotypes of P. aeruginosa PA14
and two DMS3-lysogenized strains. (A) Biofilm formation assessed by
crystal violent staining of biofilms grown in microtiter wells for 8 h.
(B) Quantification of staining of wells in panel A after solubilization
with acetic acid and measurement of optical density at 550 nm
(OD550). (C) CFU per well of biofilm bacteria. (D) Phase-contrast
micrographs of air-liquid interface of biofilms grown in microtiter
wells. Experiments displayed in panels A to D were conducted in a
polyvinylchloride microtiter plate assay in M63 minimal medium supplemented with arginine (0.4%) and MgSO4 (1 mM); incubation was at
37°C for 3 h. Bars, 20 m. (E) Photographs of representative swarming
assays after ⬃16 h of growth.

LysNeg6 cells than WT cells attached at this time point (47 ⫾
10 versus 109 ⫾ 11, respectively; P ⬍ 0.00001). In addition,
these lysogenized strains were also inhibited for swarming motility (Fig. 1E). Like biofilm formation, swarming represents a
form of bacterial group behavior (15), suggesting that lysogeny
by DMS3 interferes with at least two P. aeruginosa group behaviors. The planktonic growth rates of these lysogenized
strains were similar to that of uninfected P. aeruginosa PA14
(Fig. 2A). Twitching and swimming, two other forms of motility in P. aeruginosa, were not affected in these lysogenized
strains (data not shown).
To determine whether altered biofilm formation and swarming were a common consequence of DMS3 infection, we analyzed additional DMS3-lysogenized strains. Eighty-three of 86
lysogenized strains tested were unable to form biofilms or
swarm; however, three independently isolated lysogenized
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FIG. 2. Quantifying growth and phage production. (A) Planktonic
growth of the WT Pseudomonas aeruginosa PA14 (triangles), a biofilmnegative lysogenized strain (LysNeg6; squares), and a biofilm-positive
transposon mutant derivative of LysNeg6 (LysNeg6 33310::TnM mutant; diamonds). (B) Phage production in PFU/well of a biofilm-negative lysogenized strain (LysNeg6; squares) and a biofilm-positive
transposon mutant derivative of LysNeg6 (LysNeg6 33310::TnM mutant; diamonds). Phage was collected from the same growth assay
shown in panel A.

strains formed biofilms and swarmed similarly to the WT strain
(Fig. 1; LysPos6-3). Biofilm-positive and -negative lysogenized
strains show comparable planktonic growth rates, indicating
that differences in growth could not account for the change of
group behaviors (data not shown). Furthermore, phage harvested from the biofilm-positive lysogenized strains were capable of forming plaques on lawns of WT P. aeruginosa PA14 and
produced biofilm- and swarming-inhibited lysogenized strains
(data not shown). These results suggest that the biofilm-positive lysogens are not the result of a defective variant of DMS3
but rather represent an altered host response to DMS3 lysogeny. These data indicate that lysogeny alone is insufficient to
explain the loss of biofilm formation and swarming. The biofilm-positive lysogenized strains are discussed in more detail
below.
Sequencing the genome of DMS3 reveals similarity to Mulike phages. To further explore the molecular mechanism by
which DMS3 lysogeny inhibits biofilm formation and swarming
motility, we determined the sequence and annotated the genome
of DMS3 (Fig. 3; also see Table S2 in the supplemental material
and http://www.dartmouth.edu/⬃gotoole/Phage/index.htm).
The complete phage genome of DMS3 is 35,403 bp, which is
smaller than the original predicted length of 50 to 65 kb based
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FIG. 3. Map of the DMS3 genome. The arrows represent the predicted phage DMS3 ORFs and the predicted direction of gene transcription,
with the ORF number appearing in bold above the arrow (see Table S2 in the supplemental material for more details regarding each ORF). Black
arrows represent genes that were at least partially detected by both GeneMark.hmm and BLASTX, while gray arrows represent genes that were
detected only by GeneMark.hmm. White areas represent intergenic regions. The organisms and phages included in the similarity profile were
selected for having matches based on BLASTP expect values of less than 1e–19. The bacteriophage genomic sequences in the alignment and the
abbreviation for each organism can be found in the lower right of the figure. The boxes labeled other (OT) represent similarity with expect values
of less than 1e-19 for an organism that is not one of the 13 listed. The shaded boxes under each gene represent different degrees of similarity to
detected genes based on the BLASTP expect values (the key is in the lower right of the figure). The “#” symbol represents the organism with the
lowest expect value from BLASTP when the corresponding DMS3 ORF was analyzed. The “&” symbol indicates the organism most closely related
to the DMS3 ORF by phylogenic analysis. The genes contained in each transcriptional unit are listed in the upper right of the figure.

on pulsed-field gel electrophoresis (7). Fifty-two (52) ORFs
were predicted from the genome sequence. It is immediately
clear from the analyses of the sequence data that DMS3 has a
high degree of similarity to bacteriophage D3112 (Fig. 3; also
see Table S2 in the supplemental material), a phage with
genomic similarity to Mu-like phages and morphological similarity to -like phages (51). Of the 52 putative ORFs identified
in DMS3, 42 of the predicted gene products showed similarity
by expect values of under 1e–19 to a protein predicted for
D3112. There was also a high degree of similarity to proteins
from the B3 phage among predicted ORFs of the DMS3 genome.
The majority of the predicted genes are transcribed in the
positive orientation, with only ORFs DMS3-1 and ⫺25 transcribed in the reverse direction. This transcriptional organization is common among bacteriophages and is similar to the
organization of bacteriophages D3112, B3, MP22, and Mu (4,
17, 33, 51). As was the case with D3112 (51), no tRNA molecules were detected in the genome.

Mapping of the DMS3 lysogens suggests random insertion
in the PA14 genome. Ojha and colleagues have reported that
lysogeny by the mycobacterial phage Bxb1 disrupted biofilm
formation by insertion of the phage into a specific gene location, a groEL homolog required for mycolic acid synthesis (36).
To address the possibility that a similar mechanism was at work
in DMS3, we used arbitrary primed PCR to determine the
insertion locations of six DMS3 lysogens. Consistent with the
sequence similarity of DMS3 to Mu, a phage that inserts randomly into the host genome (32), the phage attachment sites of
all DMS3 lysogens mapped to unique insertion locations (Table 2). Therefore, our data argue against a model in which
DMS3 attachment to a single genetic locus is responsible for
the loss of biofilm formation and swarming motility.
Isolation of mutations that restore biofilm formation to a
DMS3-lysogenized strain. To investigate the basis of DMS3mediated inhibition of biofilm formation and swarming, we
transposon mutagenized a biofilm-negative lysogenized strain,
LysNeg6, and screened ⬃5,000 mutants for the restoration of
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TABLE 2. Insertion sites of six DMS3 lysogens

Lysogen

Biofilm
phenotype

LysNeg2

Inhibited

LysNeg6

Inhibited

LysNeg8

Inhibited

LysNeg10

Inhibited

LysPos5

Intact

LysPos6-3

Intact

Insertion site in
PA14 genome in
intergenic region
between:

PA14_09410 and
PA14_09400
PA14_34670 and
PA14_34660
PA14_13350 and
PA14_13340
PA14_64450 and
PA14_64460
PA14_32650 and
PA14_32640
PA14_33380 and
PA14_33370

Corresponding genes
in strain PA01

PA4216 and PA4217
PA2318 and PA2320
PA3908 and PA3909
PA4873 and PA4874
PA2473 and PA2474
PA2421 and PA2422

biofilm formation and swarming. One of these biofilm-restored
transposon mutations mapped to the PA14_33310 locus: this
mutant is hereafter designated as the LysNeg6 33310::TnM
mutant. The planktonic growth of this mutant was similar to
that of its parent strain (Fig. 2A).
Levels of phage production were also comparable during the
log phase of growth; however, at 24 h we noted PFU of approximately 1 log greater for the parent DMS3 lysogenized
strain, LysNeg6, than that for the LysNeg6 33310::TnM mutant
(Fig. 2B).
We considered the possibility that the improved biofilm formation noted for the LysNeg6 33310::TnM mutant was the
result of a reduced rate of lysis and thus phage production
compared with what was seen for LysNeg6. To address this
possibility, we reduced the phage production in the parent
lysogenized strain, LysNeg6, by expression of the DMS3 crepressor from a plasmid. The c-repressor protein represses
the activation of phage genes associated with the transition of
Mu-like bacteriophages to the lytic cycle. Although the expression of the c-repressor resulted in an approximately 2-log reduction in PFU in the transformed strain (Fig. 4A), biofilm
formation was not restored (Fig. 4B).
We also hypothesized that higher initial levels of free phage
in LysNeg6 might account for our observation of reduced biofilm formation compared to that for the LysNeg6 33310::TnM
mutant. However, increasing the starting phage concentration
to levels exceeding those associated with the parent lysogenized strain did not inhibit biofilm formation by the LysNeg6
33310::TnM mutant (data not shown). We therefore concluded
that the differences observed in phage production in late-phase
cultures between the parent DMS3-lysogenized strain and the
transposon mutant did not explain the restoration of biofilm
formation in the mutant.
Analysis of the CRISPR region of P. aeruginosa PA14. Analysis of PA14_33310 and the surrounding genes revealed six
ORFs with sequence similarity to the previously described
cas genes (13). Moreover, this region was flanked by two
CRISPRs, one in an intergenic region between PA14_33290 and
PA14_33300 (designated CRISPR-1) and another CRISPR annotated in the PA14 genome sequence as the PA14_33360 locus
(hereafter designated as CRISPR-2) (Fig. 5).
CRISPRs are typically organized as a set of 20- to 30-bp
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direct repeats alternating with 20 to 30 bp of nonrepeating
spacer sequences (45). CRISPR-2 has 22 identical direct repeats and 21 nonrepeated spacer regions. With the exception
of a 1-base substitution, the CRISPR-2 direct repeat has the
identical sequence of the CRISPR-1 direct repeat, although
the two CRISPRs are oriented divergently. The sequence
and organization of the P. aeruginosa PA14 CRISPR region
are similar to those of the CRISPR region of Yersinia pestis
(14, 40).
CRISPR spacers have been previously noted to contain sequences similar to portions of phage genes (45). Notably, our
analysis revealed that the entire second 32-bp spacer sequence
of CRISPR-2 is identical to a region of the phage gene
DMS3-24 (Fig. 3). DMS3-24 is in the predicted fourth transcriptional unit of DMS3 and shows a high degree of similarity
to p24 of phage D3112. Although annotated as a hypothetical
protein, it is suspected to be an analog of the c gene in bacteriophage Mu (51). The c gene acts as a positive regulator of
transcription of four known late gene promoters in Mu that are
essential for the cell to enter the lytic cycle (16, 29). In the fifth
spacer of CRISPR-2, the first 25 of 32 bp are identical to a
region of the phage gene DMS3-13 (Fig. 3). DMS3-13 is in the
third predicted transcriptional unit of DMS3. ORFs DMS3-13
to -17 all show relatively weak similarity to their D3112 counterparts by BLASTP expect values and no similarity to any
other genes in the protein database. Other spacers with sequence similarity to bacteriophages, such as ⌽CTX, F116, and
B3, were found in CRISPR-1 and -2 (Fig. 5). However, there

FIG. 4. Reducing phage production does not rescue the biofilm
formation defect of lysogenized strains. (A) Phage titer of LysNeg6
containing the pDMS3Early construct and the empty pMQ78 vector
was assayed as described in Materials and Methods. (B) Biofilm formation of WT and LysNeg6 containing the pDMS3Early construct and
the pMQ78 vector control was assayed as described in Materials and
Methods. OD550, optical density at 550 nm.
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FIG. 5. CRISPR region of P. aeruginosa PA14. Shown in the center of the figure is the chromosomal organization of the CRISPR genomic
region, including the two CRISPRs and the CRISPR-associated (cas) genes. The PA14 gene designation is listed above each gene, and the
corresponding homolog from Y. pestis is shown below each gene. The sizes of the ORFs are as follows: for PA14_33300, 504 bp; for PA14_33310,
1,029 bp; for PA14_33320, 984 bp; for PA14_33330, 1,305 bp; for PA14_33340, 3,231 bp; and for PA14_33350, 975 bp. CRISPR-2 is annotated as
PA14_33360 in the PA14 genome and is 1,395 bp. The organization of the CRISPRs is also shown. Black boxes indicate repeats, and gray boxes
indicate spacers containing identical or partial nucleotide sequence matches from the indicated bacteriophages. The appropriate spacer number
is listed above each spacer with known sequence identity to a phage, as is the last spacer number, which indicates the total number of spacers in
each CRISPR.

were no spacers with sequence similarity to DMS3 identified in
CRISPR-1.
Genetic analysis of the CRISPR and cas genes. The role of
the cas genes in DMS3-mediated inhibition of biofilm formation and swarming was first confirmed by analysis of additional
transposon mutants of P. aeruginosa PA14 with insertions in
this region, which were available from a defined transposon
library (23). DMS3-lysogenized strains created from strains
carrying mutations in cas genes were isolated and tested for
biofilm formation and swarming. Lysogenized strains carrying
transposon mutations in PA14_33310, PA14_33320, PA14_33330,
and PA14_33340 were intact for biofilm formation and swarming
(not shown). However, lysogenized mutants of PA14_33350, a
locus with sequence similarity to the cas1 gene, were inhibited for
biofilm formation and swarming. Because a transposon mutant of
PA14_33300 was not available, we constructed a clean deletion of
this gene and found that when lysogenized with DMS3, the corresponding strain was intact for biofilm formation and swarming
(not shown).
A clean deletion of PA14_33310 was also constructed, and as
predicted, when the corresponding strain was lysogenized with
DMS3, biofilm formation and swarming were intact (Fig. 6).
The phenotype of the lysogenized PA14_33310 mutant could
be complemented by providing the gene on a plasmid (Fig. 6).
These data provide strong evidence that the phenotypic
changes we observed for the transposon mutants were due to
disruptions of the targeted cas genes rather than polar effects
on non-cas genes.
Mutants carrying deletions of CRISPR-1 and CRISPR-2
were also constructed. The CRISPR-1 deletion mutants responded to DMS3 lysogeny in a manner similar to that seen for
WT P. aeruginosa PA14, with inhibited biofilm formation and
swarming (not shown). In contrast, DMS3-lysogenized cells
prepared using the CRISPR-2 deletion mutant displayed intact
biofilm formation and swarming (not shown). It is worth noting

that CRISPR-2 but not CRISPR-1 contains spacers with sequences derived from DMS3. Taken together, these data indicate that loss or disruption of CRISPR-2, or five of the six cas
genes, results in a restoration of biofilm formation and swarming in DMS3-lysogenized cells.
As noted above, we found that planktonic growth of the
DMS3-lysogenized strain carrying a transposon in PA14_33310
(this strain is designated the LysNeg6 33310::TnM mutant) was
unchanged compared with what was seen for the LysNeg6
parent (Fig. 2A). In contrast, the measured PFU were reduced
in the LysNeg6 33310::TnM mutant compared to LysNeg6
(Fig. 2B). To investigate whether or not this pattern was repeated in other lysogenized strains containing mutations in the
CRISPR region, we measured CFU/ml and PFU/ml for the
DMS3-lysogenized strains containing mutations in CRISPR2
or the cas genes. CFU/ml and PFU/ml were determined both
at inoculation and after 24 h of growth in LB. Consistent with
our earlier results, there were minimal differences in CFU/ml
values among the strains at either time point. However, plaque
formation was reduced ⬃10-fold for the lysogenized strain
carrying mutations in CRISPR2 or the cas genes from what
was seen for the LysNeg6 parent, with the exception of the
lysogenized strain mutated in the PA14_33350 gene (data not
shown). This is noteworthy because a mutation in PA14_33350
also failed to restore biofilm formation and swarming in the
presence of DMS3 lysogeny. However, this ⬃10-fold reduction
in PFU could not explain the restoration of biofilm formation
by the LysNeg6 strain, as we have shown that a ⬎100-fold
reduction in phage titer upon the expression of the DMS3
c-repressor could not restore biofilm formation to a biofilmnegative lysogenized strain (Fig. 4).
Biofilm-positive lysogenized strains carry deletions of the
cas genes. A role for the cas genes in phage-mediated inhibition of biofilm formation was further supported by the analysis
of the two original DMS3-lysogenized strains that were intact
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FIG. 6. Biofilm and swarming phenotypes of PA14_33310 mutants and their response to DMS3 lysogeny. (A) Photographs of representative
swarming assays after 24 h of growth of WT Pseudomonas aeruginosa PA14, a biofilm-negative lysogenized strain (LysNeg6), a mutant with a clean
deletion of PA14_33310 (⌬33310), and the clean deletion of PA14_33310 expressing the PA14_33310 from a plasmid (⌬33310 ⫹ pMQ70-33310).
DMS3 lysogens of these mutants are noted with the prefix Lys. (B) Biofilm formation assessed by crystal violet staining of biofilms grown in
polyvinylchloride microtiter wells. (C) Quantification of staining of microtiter wells after solubilization with acetic acid and measurement of optical
density at 550 nm (OD550). Experiments displayed in panels B and C were conducted in a polyvinylchloride microtiter plate assay in M63 minimal
medium supplemented with arginine (0.4%) and MgSO4 (1 mM); incubation was at 37°C for 24 h. Similar results were obtained for biofilms assayed
at 8 h (not shown). The empty vector pMQ70 had no effect on any of the phenotypes shown (data not shown).

for biofilm formation (LysPos5 and LysPos6-3). qRT-PCR
analysis revealed that, while highly expressed in nonlysogenized P. aeruginosa PA14 and the biofilm-negative lysogenized
strains, the PA14_33300, PA14_33310, and PA14_33320 genes
were not expressed in either of the biofilm-positive lysogenized
strains (Fig. 7A). Attempts to PCR amplify any part of the
CRISPR region of the biofilm-positive lysogenized strains were
unsuccessful, indicating a loss or disruption of this region.
Interestingly, analysis of the P. aeruginosa PAO1 sequence
revealed that the entire CRISPR region is absent from this
sequenced strain of P. aeruginosa. Consistent with our findings,
DMS3-lysogenized strains of P. aeruginosa PA01 are not inhibited for biofilm formation (data not shown). We were unable to generate lysogens to P. aeruginosa PAK because this
strain is resistant to DMS3 infection, so we were unable to
assess the consequences of lysogeny on biofilm formation and
swarming.
Expression of the cas genes in planktonic and biofilm
growth conditions. We assessed the expression of selected cas
genes in planktonic and attached bacteria taken from the same
culture vessel after 30 min of incubation (see Materials and
Methods for details). We found a small, statistically nonsignificant reduction in the expression of PA14_33310 (Fig. 7B) and
PA14_33330 (not shown) 30 min after WT P. aeruginosa attached to an abiotic surface. As shown in Fig. 7A, there was
also no difference between the cas gene expression of the WT
and those of two different biofilm-negative lysogenized strains.

Therefore, it appears that transcriptional regulation of the cas
genes does not contribute to the differential impact of this
region in lysogenized versus nonlysogenized strains.
DISCUSSION
CRISPR regions have been implicated in bacterial resistance to lytic bacteriophage infection (2, 45). Barrangou and
colleagues recently described the association of acquired immunity to a lytic bacteriophage infection with the presence of
DNA sequences derived from the infecting phage in the spacers of CRISPRs and furthermore demonstrated that mutations
in those spacers resulted in a loss of phage resistance (2). They
also found that mutation of certain cas genes resulted in the
loss of resistance to lytic phage in previously resistant strains,
while mutations in different cas genes produced strains that
were unable to acquire phage resistance (2). The mechanism
by which phage DNA is incorporated into CRISPR spacers,
and how these spacers confer resistance to infection by the
same phage, have not been established. There is recent evidence that some transcribed CRISPRs are degraded into small
RNAs corresponding to each spacer with half of the repeated
region on either end (5, 46, 47). Makarova and colleagues have
suggested that these small RNAs serve as the basis for an RNA
interference system directed at genes expressed by bacteriophages, resulting in resistance to phage infection (27). The
existing model for CRISPR-mediated bacteriophage resistance
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FIG. 7. qRT-PCR analysis of the PA14_33310 gene in DMS3 lysogens. (A) qRT-PCR was performed as described in Materials and
Methods, and expression was normalized to the rplU gene. Levels of
expression of the cas gene PA14_33310 were similar for WT P. aeruginosa PA14 and two DMS3-lysogenized strains which are inhibited for
biofilm formation and swarming, LysNeg8 and LysNeg6. However, no
expression was detected for two biofilm- and swarming-positive lysogenized strains, LysPos6-3 and LysPos5. Comparable results were obtained when expression of two other cas genes, PA14_33300 and
PA14_33320, was assessed (not shown). (B) qRT-PCR was performed
on the WT strain grown planktonically or attached to a surface. Shown
is the relative expression for the PA14_33310 gene. The expression of
the PA14_33310 gene under planktonic conditions is arbitrarily set at
1. ns, not significant (P ⬎ 0.05).

proposes that CRISPR gene products disrupt phage gene transcription or production of these gene products (9, 45).
As discussed above, DMS3-lysogenized strains prepared using
a mutation containing a transposon insertion in PA14_33350
(cas1), like WT P. aeruginosa PA14, were unable to form a biofilm
or swarm, whereas DMS3-lysogenized strains derived from mutations in all the other cas genes had intact biofilm formation and
swarming. The predicted function for PA14_33350 (cas1) is that
of an integrase (14). Previous reports have speculated that integrase homologs participate in the process of integration of new
phage DNA sequences into CRISPRs (2, 27). One might hypothesize that subsets of cas genes, such as PA14_33350 (cas1), are
devoted to the generation of new content in CRISPR spacers,
while other cas genes are involved in the response to phage
infection. Thus, since P. aeruginosa PA14 already contains
CRISPR spacers homologous to DMS3 genes, it is perhaps not
unexpected that deletion of PA14_33350 (cas1), a gene presumably involved in the incorporation of new spacers, did not result in
alteration of the response to DMS3 lysogeny.
It is important to note that the presence of DMS3 sequences
in the second and fifth spacers of CRISPR-2 in unlysogenized
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Pseudomonas PA14 did not prevent infection by DMS3. Furthermore, we observed that a strain with an intact CRISPR
region, LysNeg6, had a high rate of phage production in stationary-phase cultures compared to a strain with an altered
CRISPR region, the LysNeg6 33310::TnM mutant, arguing
against CRISPR-mediated suppression of the DMS3 lytic cycle
in P. aeruginosa PA14. However, the low phage titer produced
by the biofilm-positive lysogenized strain carrying a mutation
in the cas genes compared to that for the biofilm-negative
lysogenized strain could not account for the restored biofilm
phenotype of the biofilm-positive lysogenized strain (Fig. 4).
It may be that the current CRISPR spacer content in P.
aeruginosa PA14 is ineffective at resisting infection, while incorporation of different spacers would create a resistant isolate. Alternatively, it is possible that CRISPR regions are
adapted to different functions in different species and/or play
distinct roles in response to infection by lytic versus lysogenic
phages. This different role for CRISPRs might not be unexpected given the diversity observed among CRISPR regions.
Forty-five different cas genes have been identified; repeat sizes
can range from 24 to 47 bp, and the number of repeats can
range from 2 to 249 (45). Perhaps the P. aeruginosa PA14
CRISPR region has evolved to alter the effects of lysogeny in
addition to, or perhaps instead of, resisting phage infection or
lysis. What does seem clear is that CRISPR regions are a
genetic locus in which multiple functions related to the bacterial response to phage infection are located and organized.
Why would biofilm formation be altered by P. aeruginosa in
response to lysogeny? CRISPR-mediated alteration of biofilm
formation and swarming may be a strategy of the bacterium for
limiting the effects of bacteriophage dissemination in bacterial
communities. In other words, phage-infected bacteria quarantine themselves from biofilms and other group behaviors to
reduce the chances of infecting the larger community. Alternatively, inhibition of biofilm formation and swarming may
provide an unknown survival advantage to phage DMS3. What
is clear is that the changes we observed in biofilm formation
and swarming depends both on phage DMS3 infection and on
the presence of the P. aeruginosa PA14 CRISPR region. This
interaction may represent a novel mechanism of lysogenic conversion. More work is necessary to understand the role of this
process in the ecology of P. aeruginosa, as well as to determine
the mechanism by which biofilm formation is disrupted during
DMS3 lysogeny and the role of the CRISPRs and cas genes in
this process.
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